Immunological profile of an infant treated with integrase inhibitor from the neonatal period

• Lucia Taramasso,
• Chiara Dentone,
• Paola Tatarelli,
• Bianca Bruzzone,
• Francesco Marras,
• Andrea De Maria,
• Cristina Gotta,
• Elio Castagnola,
• Gilberto Filaci,
• Claudio Viscoli,
• Daniela Fenoglio,
• Antonio Di Biagio

Affiliations

Lucia Taramasso

University of Genoa, Department of Health Sciences (DISSAL), Genoa, Italy; Infectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Chiara Dentone

Infectious Diseases Department, Sanremo Hospital

Paola Tatarelli

University of Genoa, Department of Health Sciences (DISSAL), Genoa, Italy; Corresponding author: Paola Tatarelli, Dipartimento di Scienze della Salute (DISSAL), University of Genoa, Via Pastore, 1 Genova, 16132, Italy

Bianca Bruzzone

Hygiene Unit, Policlinico San Martino Hospital, Genoa, Italy

Francesco Marras

Molecular Immunology, University of Genoa, Genoa, Italy

Andrea De Maria

Molecular Immunology, University of Genoa, Genoa, Italy

Cristina Gotta

Department of Obstetrics and Gynecology, Policlinico San Martino Hospital, Genoa, Italy

Elio Castagnola

Infectious Diseases Unit, Istituto Giannina Gaslini, Genoa, Italy

Gilberto Filaci

Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy

Claudio Viscoli

University of Genoa, Department of Health Sciences (DISSAL), Genoa, Italy; Infectious Diseases Unit, Policlinico San Martino Hospital, Genoa, Italy

Daniela Fenoglio

Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy

Antonio Di Biagio

Infectious Diseases Unit, Policlinico San Martino Hospital, Genoa, Italy